Profile
Eric Rojas is currently the Vice President of Investor Relations at Stoke Therapeutics, Inc. He previously worked as a Senior Director of Investor Relations at Shire Plc.
Eric Rojas active positions
| Companies | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Investor Relations Contact | - |
Former positions of Eric Rojas
| Companies | Position | End |
|---|---|---|
| SHIRE | Investor Relations Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| STOKE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Eric Rojas